Clinical Impact of Genetic Diagnosis of Sensorineural Hearing Loss in Adults.
Journal
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504
Informations de publication
Date de publication:
01 12 2022
01 12 2022
Historique:
pubmed:
4
10
2022
medline:
15
11
2022
entrez:
3
10
2022
Statut:
ppublish
Résumé
Adult genetic sensorineural hearing loss (SNHL) may be underestimated. The diagnosis of genetic hearing loss is challenging, given its extreme genetic and phenotypic heterogeneity, particularly in adulthood. This study evaluated the utility of next-generation sequencing (NGS) in the etiological diagnosis of adult-onset SNHL. Adults (>16 yr old) with SNHL were recruited at the Otolaryngology Department at Marqués de Valdecilla University Hospital (Spain). Environmental factors, acoustic trauma, endolymphatic hydrops, and age-related hearing loss were excluding criteria. An NGS gene panel was used, including 196 genes (OTOgenics v3) or 229 genes (OTOgenics v4) related to syndromic and nonsyndromic hearing loss. Sixty-five patients were included in the study (average age at the onset of SNHL, 41 yr). Fifteen pathogenic/likely pathogenic variants considered to be causative were found in 15 patients (23% diagnostic yield) in TECTA (4), KCNQ4 (3), GJB2 (2), ACTG1 (1), COL2A1 (1), COCH (1), COCH/COL2A1 (1), STRC (1), and ABHD12 (1). Three patients had syndromic associations (20% of patients with genetic diagnosis) that had not been previously diagnosed (two Stickler type I and one polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, cataract syndrome). Seven variants of unknown significance were found in COL11A1 (1), GSMDE (2), DNTM1 (1), SOX10 (1), EYA4 (1), and TECTA (1). NGS gene panels can provide diagnostic yields greater than 20% for adult SNHL, with a significant proportion of variant of unknown significance that could potentially contribute to increasing diagnostic output. Identifying a genetic cause enables genetic counseling, provides prognostic information and can reveal unrecognized syndromes contributing to an accurate management of their associated manifestations.
Sections du résumé
HYPOTHESIS
Adult genetic sensorineural hearing loss (SNHL) may be underestimated.
BACKGROUND
The diagnosis of genetic hearing loss is challenging, given its extreme genetic and phenotypic heterogeneity, particularly in adulthood. This study evaluated the utility of next-generation sequencing (NGS) in the etiological diagnosis of adult-onset SNHL.
MATERIALS AND METHODS
Adults (>16 yr old) with SNHL were recruited at the Otolaryngology Department at Marqués de Valdecilla University Hospital (Spain). Environmental factors, acoustic trauma, endolymphatic hydrops, and age-related hearing loss were excluding criteria. An NGS gene panel was used, including 196 genes (OTOgenics v3) or 229 genes (OTOgenics v4) related to syndromic and nonsyndromic hearing loss.
RESULTS
Sixty-five patients were included in the study (average age at the onset of SNHL, 41 yr). Fifteen pathogenic/likely pathogenic variants considered to be causative were found in 15 patients (23% diagnostic yield) in TECTA (4), KCNQ4 (3), GJB2 (2), ACTG1 (1), COL2A1 (1), COCH (1), COCH/COL2A1 (1), STRC (1), and ABHD12 (1). Three patients had syndromic associations (20% of patients with genetic diagnosis) that had not been previously diagnosed (two Stickler type I and one polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, cataract syndrome). Seven variants of unknown significance were found in COL11A1 (1), GSMDE (2), DNTM1 (1), SOX10 (1), EYA4 (1), and TECTA (1).
CONCLUSION
NGS gene panels can provide diagnostic yields greater than 20% for adult SNHL, with a significant proportion of variant of unknown significance that could potentially contribute to increasing diagnostic output. Identifying a genetic cause enables genetic counseling, provides prognostic information and can reveal unrecognized syndromes contributing to an accurate management of their associated manifestations.
Identifiants
pubmed: 36190904
doi: 10.1097/MAO.0000000000003706
pii: 00129492-202212000-00008
doi:
Substances chimiques
EYA4 protein, human
0
Trans-Activators
0
STRC protein, human
0
Intercellular Signaling Peptides and Proteins
0
ABHD12 protein, human
EC 3.1.1.23
Monoacylglycerol Lipases
EC 3.1.1.23
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1125-1136Informations de copyright
Copyright © 2022, Otology & Neurotology, Inc.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose or external funding to declare.
Références
Panza F, Lozupone M, Sardone R, et al. Sensorial frailty: Age-related hearing loss and the risk of cognitive impairment and dementia in later life. Ther Adv Chronic Dis 2019;10:20406.
Hyams AV, Hay-McCutcheon M, Scogin F. Hearing and quality of life in older adults. J Clin Psychol 2018;74:1874–83.
Cunningham LL, Tucci DL. Hearing loss in adults. N Engl J Med 2017;377:2465–73.
Michels TC, Duffy MT, Rogers DJ. Hearing loss in adults: Differential diagnosis and treatment. Am Fam Physician 2019;100:98–108.
Ciorba A, Corazzi V, Bianchini C, et al. Autoimmune inner ear disease (AIED): A diagnostic challenge. Int J Immunopathol Pharmacol 2018;32:205.
Peneda JF, Lima NB, Monteiro F, et al. Immune-mediated inner ear disease: Diagnostic and therapeutic approaches. Acta Otorrinolaringol Esp (Engl Ed) 2019;70:97–104.
Rosati R, Jamesdaniel S. Environmental exposures and hearing loss. Int J Environ Res Public Health 2020;17:4879.
Cabanillas R, Dineiro M, Cifuentes GA, et al. Comprehensive genomic diagnosis of non-syndromic and syndromic hereditary hearing loss in Spanish patients. BMC Med Genomics 2018;11:58.
Cabanillas Farpon R, Cadinanos Banales J. Hereditary hearing loss: genetic counselling. Acta Otorrinolaringol Esp 2012;63:218–29.
Chen S, Dong C, Wang Q, et al. Targeted next-generation sequencing successfully detects causative genes in Chinese patients with hereditary hearing loss. Genet Test Mol Biomarkers 2016;20:660–5.
Schenkel LC, Kerkhof J, Stuart A, et al. Clinical next-generation sequencing pipeline outperforms a combined approach using sanger sequencing and multiplex ligation-dependent probe amplification in targeted gene panel analysis. J Mol Diagn 2016;18:657–67.
Oza AM, DiStefano MT, Hemphill SE, et al. Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing loss. Hum Mutat 2018;39:1593–613.
Richard DJ, Cubeddu L, Urquhart AJ, et al. hSSB1 interacts directly with the MRN complex stimulating its recruitment to DNA double-strand breaks and its endo-nuclease activity. Nucleic Acids Res 2011;39:3643–51.
Puente XS, Pinyol M, Quesada V, et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011;475:101–5.
Valdes-Mas R, Bea S, Puente DA, Lopez-Otin C, Puente XS. Estimation of copy number alterations from exome sequencing data. PLoS One 2012;7:e51422.
Hildebrand MS, Morin M, Meyer NC, et al. DFNA8/12 caused by TECTA mutations is the most identified subtype of nonsyndromic autosomal dominant hearing loss. Hum Mutat 2011;32:825–34.
Capalbo A, Valero RA, Jimenez-Almazan J, et al. Optimizing clinical exome design and parallel gene-testing for recessive genetic conditions in preconception carrier screening: Translational research genomic data from 14,125 exomes. PLoS Genet 2019;15:e1008409.
Zelante L, Gasparini P, Estivill X, et al. Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet 1997;6:1605–9.
Morell RJ, Kim HJ, Hood LJ, et al. Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med 1998;339:1500–5.
Pampanos A, Neou P, Iliades T, et al. Pseudodominant inheritance of DFNB1 deafness due to the common 35delG mutation. Clin Genet 2000;57:232–4.
Marlin S, Garabedian EN, Roger G, et al. Connexin 26 gene mutations in congenitally deaf children: Pitfalls for genetic counseling. Arch Otolaryngol Head Neck Surg 2001;127:927–33.
Mese G, Londin E, Mui R, Brink PR, White TW. Altered gating properties of functional Cx26 mutants associated with recessive non-syndromic hearing loss. Hum Genet 2004;115:191–9.
Mese G, Valiunas V, Brink PR, White TW. Connexin26 deafness associated mutations show altered permeability to large cationic molecules. Am J Physiol Cell Physiol 2008;295:C966–74.
Copikova J, Paderova J, Romankova V, et al. Expanding the phenotype spectrum associated with pathogenic variants in the COL2A1 and COL11A1 genes. Ann Hum Genet 2020;84:380–92.
Wilcox SA, Saunders K, Osborn AH, et al. High frequency hearing loss correlated with mutations in the GJB2 gene. Hum Genet 2000;106:399–405.
Kelley PM, Harris DJ, Comer BC, et al. Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am J Hum Genet 1998;62:792–9.
Fiskerstrand T, H'Mida-Ben Brahim D, Johansson S, et al. Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism. Am J Hum Genet 2010;87:410–7.
Freddi S, Savarirayan R, Bateman JF. Molecular diagnosis of stickler syndrome: A COL2A1 stop codon mutation screening strategy that is not compromised by mutant mRNA instability. Am J Med Genet 2000;90:398–406.
Sun W, Huang L, Xu Y, et al. Exome sequencing on 298 Ppearly-onset high myopia: Approximately one-fourth show potential pathogenic mutations in RetNet genes. Invest Ophthalmol Vis Sci 2015;56:8365–72.
Xiong HY, Alipanahi B, Lee LJ, et al. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease. Science 2015;347:1254806.
Mandelker D, Amr SS, Pugh T, et al. Comprehensive diagnostic testing for stereocilin: An approach for analyzing medically important genes with high homology. J Mol Diagn 2014;16:639–47.
Vona B, Hofrichter MA, Neuner C, et al. DFNB16 is a frequent cause of congenital hearing impairment: Implementation of STRC mutation analysis in routine diagnostics. Clin Genet 2015;87:49–55.
Azaiez H, Booth KT, Ephraim SS, et al. Genomic landscape and mutational signatures of deafness-associated genes. Am J Hum Genet 2018;103:484–97.
Shearer AE, Black-Ziegelbein EA, Hildebrand MS, et al. Advancing genetic testing for deafness with genomic technology. J Med Genet 2013;50:627–34.
Kenna MA, Feldman HA, Neault MW, et al. Audiologic phenotype and progression in GJB2 (Connexin 26) hearing loss. Arch Otolaryngol Head Neck Surg 2010;136:81–7.
Richards AJ, Snead MP. The influence of pre-mRNA splicing on phenotypic modification in Stickler's syndrome and other type II collagenopathies. Eye (Lond) 2008;22:1243–50.
Hoffman-Andrews L. The known unknown: The challenges of genetic variants of uncertain significance in clinical practice. J Law Biosci 2017;4:648–57.
Houge G, Laner A, Cirak S, et al. Stepwise ABC system for classification of any type of genetic variant. Eur J Hum Genet 2021;30:150–9.
Shearer AE, Smith RJ. Massively parallel sequencing for genetic diagnosis of hearing loss: The new standard of care. Otolaryngol Head Neck Surg 2015;153:175–82.
Bademci G, Foster J 2nd, Mahdieh N, et al. Comprehensive analysis via exome sequencing uncovers genetic etiology in autosomal recessive nonsyndromic deafness in a large multiethnic cohort. Genet Med 2016;18:364–71.
Dineiro M, Capin R, Cifuentes GA, et al. Comprehensive genomic diagnosis of inherited retinal and optical nerve disorders reveals hidden syndromes and personalized therapeutic options. Acta Ophthalmol 2020;98:e1034–48.
Uehara N, Fujita T, Yamashita D, et al. Genetic background in late-onset sensorineural hearing loss patients. J Hum Genet 2022;67:223–30.
Costales M, Dineiro M, Cifuentes GA, et al. Clinical utility of next-generation sequencing in the aetiological diagnosis of sensorineural hearing loss in a Childhood Hearing Loss Unit. Acta Otorrinolaringol Esp (Engl Ed) 2020;71:166–74.
Alford RL, Arnos KS, Fox M, et al. American College of Medical Genetics and Genomics guideline for the clinical evaluation and etiologic diagnosis of hearing loss. Genet Med 2014;16:347–55.
Chang MY, Lee C, Han JH, et al. Expansion of phenotypic spectrum of MYO15A pathogenic variants to include postlingual onset of progressive partial deafness. BMC Med Genet 2018;19:29.
Ren Y, Landegger LD, Stankovic KM. Gene therapy for human sensorineural hearing loss. Front Cell Neurosci 2019;13:323.
Crane R, Conley SM, Al-Ubaidi MR, Naash MI. Gene therapy to the retina and the cochlea. Front Neurosci 2021;15:652215.
Carpena NT, Lee MY. Genetic hearing loss and gene therapy. Genomics Inform 2018;16:e20.